Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.50 |
| ▸ | KIF11 | P52732 | 9/20 | 0.47 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.45 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.45 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.45 |
| ▸ | ARG1 | P05089 | 1/20 | 0.44 |
| ▸ | ARG2 | P78540 | 1/20 | 0.44 |
| ▸ | NOS2 | P35228 | 3/20 | 0.43 |
| ▸ | NOS1 | P29475 | 2/20 | 0.43 |
| ▸ | NOS3 | P29474 | 1/20 | 0.43 |
| ▸ | BHMT | Q93088 | 1/20 | 0.42 |
| ▸ | BHMT2 | Q9H2M3 | 1/20 | 0.42 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | SLC7A11 | Q9UPY5 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13988062 | 1.00 | SLC7A5 (0.50) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL28948326 | 1.00 | SLC7A5 (0.50) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6542263 | 0.86 | SLC7A5 (0.50) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6542267 | 0.86 | SLC7A5 (0.50) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL3715550 | 0.84 | SLC7A5 (0.48) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL9463162 | 0.84 | SLC7A5 (0.48) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| Hydrochloric Acid SCHEMBL9462892 | 0.84 | SLC7A5 (0.48) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL6231968 | 0.84 | SLC7A5 (0.48) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL15600074 | 0.82 | SLC7A5 (0.46) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 | |
| SCHEMBL8518857 | 0.82 | SLC7A5 (0.46) | SLC7A5KIF11SLC1A3SLC1A2SLC1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119894525-A | Mucispirillum compositions and methods of treating cancer | 哈佛大学校长及研究员协会 | 2025-04-25 | — | — | CN | disclosed |
| CN-115677482-A | Synthesis method of chiral alpha-hydroxy acid | 上海吉奉生物科技有限公司 | 2023-02-03 | — | — | CN | disclosed |
| US-20220193063-A1 | METABOLITES OF GLP1R AGONISTS | PFIZER INC. (US) | 2022-06-23 | — | — | US | disclosed |
| US-9468625-B2 | Organonitro thioether compounds and medical uses thereof | EPICENTRX, INC. (US) | 2016-10-18 | — | — | US | disclosed |
| US-20160081981-A1 | ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF | RADIORX, INC. | 2016-03-24 | — | — | US | disclosed |
| US-9139519-B2 | Organonitro thioether compounds and medical uses thereof | EPICENTRX, INC. (US) | 2015-09-22 | — | — | US | disclosed |
| US-20140349988-A1 | ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF | RADIORX, INC. (US) | 2014-11-27 | — | — | US | disclosed |
| US-7507546-B2 | Methods of screening agents, conjugates or conjugate moieties for transport by a PEPT2 transporter | XENOPORT, INC. (US) | 2009-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220193063-A1 | METABOLITES OF GLP1R AGONISTS | GLP1R, GIPR, GCGR | SLC7A5 981/4885KIF11 3302/4885SLC1A3 663/4885 |
| US-20140349988-A1 | ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF | SLC22A8, SLCO2A1, SLCO2B1 | SLC7A5 564/4885KIF11 1686/4885SLC1A3 746/4885 |
| US-20160081981-A1 | ORGANONITRO THIOETHER COMPOUNDS AND MEDICAL USES THEREOF | SLC22A8, XPOT, NPM1 | SLC7A5 1266/4885KIF11 2056/4885SLC1A3 824/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.